Cargando…
ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
The COVID-19 pandemic is challenging the capacities of health systems in many countries. National healthcare services have to manage unexpected shortages of healthcare resources that have to be re-allocated according to the principles of fair and ethical prioritisation, in order to maintain the high...
Autores principales: | Catanese, Silvia, Pentheroudakis, George, Douillard, Jean-Yves, Lordick, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239531/ https://www.ncbi.nlm.nih.gov/pubmed/32423899 http://dx.doi.org/10.1136/esmoopen-2020-000804 |
Ejemplares similares
-
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020) -
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies
por: Colombo, Ilaria, et al.
Publicado: (2020) -
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
por: Curigliano, G., et al.
Publicado: (2020) -
Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017) -
ESMO Copenhagen 2016: a lung cancer ‘grand cru’
por: Douillard, Jean-Yves
Publicado: (2017)